Get the Stockscreener App
12.38
8.27%
-1.1169
Exozymes Inc stock is traded at $12.38, with a volume of 1,793.
It is down -8.27% in the last 24 hours and down -0.14% over the past month.
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
See More
Previous Close:
$13.50
Open:
$14
24h Volume:
1,793
Relative Volume:
0.33
Market Cap:
$108.61M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-8.27%
1M Performance:
-0.14%
6M Performance:
+13.61%
1Y Performance:
+0.00%
1-Day Range:
$12.95
$14.00
1-Week Range:
$12.85
$14.00
52-Week Range:
$8.86
$22.63
Exozymes Inc Stock (EXOZ) Company Profile
Name
Exozymes Inc
Sector
Industry
Phone
(626) - 415 - 1488
Address
750 ROYAL OAKS DR, MONROVIA
Compare EXOZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EXOZ
Exozymes Inc
|
12.95 | 108.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.64 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.22 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.01 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
795.45 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Exozymes Inc Stock (EXOZ) Latest News
Real time pattern detection on eXoZymes Inc. stock2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
Is eXoZymes Inc. stock entering bullish territoryWeekly Investment Summary & Growth Oriented Trade Recommendations - newser.com
eXoZymes (NASDAQ:EXOZ) Receives “Sell (E+)” Rating from Weiss Ratings - Defense World
Relative strength of eXoZymes Inc. in sector analysisQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Full technical analysis of eXoZymes Inc. stockJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
What high frequency data says about eXoZymes Inc.Inflation Watch & Weekly Momentum Stock Picks - newser.com
eXoZymes Unveils Updated Investor Presentation - TipRanks
Why analysts upgrade eXoZymes Inc. stockMarket Growth Report & Daily Volume Surge Signals - newser.com
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees - ACCESS Newswire
Cell-Free Biomanufacturing Pioneer eXoZymes Gains Strategic Positions in Federal Innovation Institute - Stock Titan
What analysts say about eXoZymes Inc stockVolatility Adjusted Trading & Free Robust Financial Gains - earlytimes.in
HCM II Acquisition Corp Stock Analysis and ForecastStock Price Divergence & Low Risk Wealth Building - earlytimes.in
Multi asset correlation models including Walgreens Boots Alliance Inc.2025 Trading Volume Trends & Growth-Oriented Investment Plans - newser.com
How hedge fund analytics apply to RDDT stock2025 Retail Activity & Daily Momentum Trading Reports - newser.com
Why Encres Dubuit (1F2) stock is a strong buy callStop Loss & Fast Momentum Entry Tips - newser.com
Why National Bank of Canada (NBC) stock could be next leaderPortfolio Gains Summary & Target Return Focused Stock Picks - newser.com
Can FTI Consulting Inc. (FCQ) stock surprise with quarterly resultsWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Is Ponsse Oyj (PNS) stock a buy before earnings resultsLayoff News & Growth Focused Stock Reports - newser.com
Is Roman DBDR Acquisition Corp. II Equity Warrant stock a buy on dipsJuly 2025 Intraday Action & Daily Entry Point Alerts - newser.com
Is Owlet Inc. stock a good choice for value investorsSell Signal & Safe Entry Trade Reports - newser.com
Is MGR stock supported by free cash flow2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
How to recover losses in Falcon s Beyond Global Inc. stockJuly 2025 Update & Low Drawdown Trading Techniques - newser.com
Will HAL Trust (HA4) stock benefit from Fed rate cutsQuarterly Profit Review & Short-Term High Return Strategies - newser.com
Why Tradeweb Markets Inc. stock attracts high net worth investorsJuly 2025 Price Swings & High Conviction Trade Alerts - newser.com
Is ITOCHU Corporation (IOC) stock bottoming after sell offBuy Signal & Fast Moving Stock Watchlists - newser.com
Why China Resources Pharmaceutical Group Limited (640) stock is a strong analyst pickMarket Weekly Review & Free High Accuracy Swing Entry Alerts - newser.com
Is eXoZymes Inc a good long term investmentInsider Selling Patterns & High Yield Trading Alerts - Early Times
D pipelineTrade Entry Summary & Proven Capital Preservation Methods - newser.com
Is ARLU stock attractive for dividend growth2025 Market Trends & Detailed Earnings Play Strategies - newser.com
HEICO Corporation stock volume spike explainedWeekly Gains Summary & Growth Oriented Trading Recommendations - newser.com
How high can eXoZymes Inc. stock goJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Is Informatica Inc. reversing from oversold territoryJuly 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Technical signs of recovery in HCM II Acquisition Corp.Market Risk Analysis & Growth Focused Entry Reports - newser.com
Exozymes Inc Stock (EXOZ) Financials Data
There is no financial data for Exozymes Inc (EXOZ). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Exozymes Inc Stock (EXOZ) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Heltzen Michael | Chief Executive Officer |
Jan 17 '25 |
Buy |
10.78 |
1,767 |
19,048 |
3,872 |
| Heltzen Michael | Chief Executive Officer |
Jan 16 '25 |
Buy |
10.72 |
121 |
1,297 |
2,105 |
| Heltzen Michael | Chief Executive Officer |
Nov 15 '24 |
Buy |
11.10 |
1,984 |
22,022 |
1,984 |
2.36%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):